How a Biomed Tech Company Raised $35.7 Million Before Going to Market

Story excerpt provided by Entrepreneur.

Written by Jane Porter.

When Charu Ramanathan founded CardioInsight in 2005, she knew she had a technology on her hands with the potential to help save people’s lives. It provided a minimally invasive way to create a 3D map of the heart’s electrical activity, one that could help in the diagnosis and treatment of heart disease. But with any technology in the biomedical space, bringing it to market would require a long and painstaking process, one involving significant research, clinical testing, regulatory approval, and most of all – funding.

Click here to read the complete article.

Originally published May 27, 2014.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: